4-butyrolactone has been researched along with uftoral in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Emi, Y; Fukui, Y; Kakeji, Y; Maehara, Y; Oki, E; Sumiyoshi, Y | 1 |
1 other study(ies) available for 4-butyrolactone and uftoral
Article | Year |
---|---|
Pharmacokinetics of gamma-hydroxybutylic acid (GHB) and gamma-butyrolactone (GBL), the anti-angiogenic metabolites of oral fluoropyrimidine UFT, in patients with gastric cancer.
Topics: 4-Butyrolactone; Administration, Oral; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Drug Combinations; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 2007 |